Miraxol (pramipexole dihydrochloride monohydrate) tablets 0.25 mg. №30


Manufacturer: Ukraine



Treatment of symptoms of idiopathic Parkinson’s disease in adults, as monotherapy (without levodopa) or in combination with levodopa during the course of the disease until the later stages, when the effect of levodopa decreases or becomes unstable and there is a fluctuation in the therapeutic effect (the phenomenon of “on-off”). Symptomatic treatment of moderate to severe idiopathic “restless legs” syndrome in adults (doses not higher than 0.75 mg).